tiprankstipranks
VBI Vaccines (VBIV)
NASDAQ:VBIV

VBI Vaccines (VBIV) Financial Statements

2,216 Followers

VBI Vaccines Financial Overview

VBI Vaccines's market cap is currently ―. The company's EPS TTM is $-9.421; its P/E ratio is -0.07; VBI Vaccines is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 720.00K$ 485.00K$ 293.00K$ 317.00K$ 346.00K
Gross Profit$ 720.00K$ 485.00K$ 293.00K$ -2.35M$ -2.18M
EBIT$ -42.92M$ -26.32M$ -19.93M$ -23.94M$ -44.62M
EBITDA-$ -25.34M$ -22.46M$ -23.41M$ -44.08M
Net Income Common Stockholders$ -44.63M$ 12.24M$ -21.14M$ -25.21M$ -45.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 20.84M$ 40.39M$ 62.63M$ 83.55M$ 82.41M
Total Assets$ 88.32M$ 128.46M$ 155.09M$ 172.01M$ 172.16M
Total Debt$ 52.55M$ 52.37M$ 52.23M$ 51.90M$ 33.34M
Net Debt$ 31.71M$ 11.98M$ -10.40M$ -31.65M$ -49.07M
Total Liabilities$ 79.58M$ 83.44M$ 90.92M$ 88.19M$ 66.60M
Stockholders Equity$ 8.74M$ 45.02M$ 64.16M$ 83.82M$ 105.56M
Cash Flow-
Free Cash Flow-$ -21.86M$ -20.50M$ -18.57M$ -18.53M
Operating Cash Flow$ -19.21M$ -21.32M$ -19.05M$ -17.27M$ -17.45M
Investing Cash Flow$ -50.00K$ -534.00K$ -1.45M$ -1.30M$ -1.08M
Financing Cash Flow---$ 19.44M$ 0.00
Currency in USD

VBI Vaccines Earnings and Revenue History

VBI Vaccines Debt to Assets

VBI Vaccines Cash Flow

VBI Vaccines Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis